HNI Corporation reports Q1 results on May 20 with the stock having shed 40% from its February highs — a collapse that has drawn a sharp and rapid build in short positioning heading into the print.
Short interest is the dominant story here. It has climbed 24% in a single week to 5.7% of free float, and is up 21% over the past month — a meaningful acceleration that coincides almost exactly with the stock's breakdown. The ORTEX short score has risen alongside, moving from 35.8 to 39.2 over the past ten sessions, reflecting growing bearish conviction. Yet the lending market offers no amplifier: with borrow availability running at roughly 905% — well above normal — there is ample supply for new shorts to enter without any squeeze pressure, and cost to borrow remains negligible at under 0.5%.
The price damage has been severe and broad. HNI closed at $29.90 on May 15, down 11% on the week and 17.5% on the month. Close peers have also struggled — MLKN fell 11.4% on the week, dropped 12.9%, and shed 9.4% — suggesting sector-wide pressure rather than a company-specific blow-up. But HNI's decline has been sharper than most. Options traders, interestingly, have not turned notably bearish: the put/call ratio of 0.16 is only marginally above its 20-day average of 0.15, and a z-score barely above 0.4 shows no unusual hedging activity relative to recent norms.
The analyst debate runs in one clear direction, though the gap between conviction and current reality is stark. Benchmark trimmed its target from $75 to $65 on May 7 while maintaining a Buy — the sole recent analyst action of note. The consensus mean target of $69 implies roughly 130% upside from current prices, a level of implied return that reflects either deep value conviction or a consensus that has not fully repriced the stock's collapse. The valuation data supports the former argument: PE has contracted to under 7x, EV/EBITDA to 4.8x, and the price-to-book ratio has fallen below 1.0x. Bulls point to a dividend yield approaching 5% and an asset base now trading below replacement value; bears counter that exposure to commercial real estate and weak workplace demand creates structural risk that cheap multiples alone cannot offset.
Past earnings reactions provide the most cautionary context. After the May 2026 Q4 print — just weeks ago — the stock fell 4.2% on the day and a further 14.3% over the following five sessions. A similar pattern after Q3 results last April saw a 3.3% day-one decline and an additional 3.8% drift lower over the next week. The earnings report will therefore test whether the stock's collapse has already discounted another disappointing quarter, or whether a further compression in demand guidance is still ahead.
See the live data behind this article on ORTEX.
Open HNI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
